12-Feb-2026
Metlife (MET) Gets a Buy from Mizuho Securities
TipRanks (Thu, 12-Feb 7:35 AM ET)
Coal miners in spotlight as Pentagon said to plan federal support for U.S. coal-fired power plants
Seeking Alpha News (Wed, 11-Feb 1:46 AM ET)
Business Wire (Tue, 10-Feb 9:00 AM ET)
MetLife Announces Full Year and 4Q 2025 Results
Business Wire (Wed, 4-Feb 4:15 PM ET)
MetLife CFO John McCallion Provides Fourth Quarter and Full Year 2025 Financial Update Video
Business Wire (Wed, 4-Feb 4:15 PM ET)
MetLife CEO and CFO to Speak at Bank of America Securities 2026 Financial Services Conference
Business Wire (Thu, 29-Jan 4:15 PM ET)
MetLife Recognized as Industry Leader on Fortune World's Most Admired Companies 2026 List
Business Wire (Wed, 28-Jan 9:00 AM ET)
MetLife to Hold Combined Earnings and Outlook Conference Call
Business Wire (Wed, 7-Jan 4:15 PM ET)
New MetLife Data Finds Rising Cost Pressures Outpacing Gains in Workforce Well-Being
Business Wire (Wed, 7-Jan 9:00 AM ET)
MetLife Declares First Quarter 2026 Common Stock Dividend
Business Wire (Tue, 6-Jan 4:15 PM ET)
MetLife is one of the largest life insurers in the US by assets and provides a variety of life insurance and annuity products. It is organized into six segments: Group Benefits, Retirement and Income Solutions, Asia, Latin America, Europe/Middle East/Africa (EMEA), and MetLife Holdings (products in run-off). Group Benefits and RIS are US-based, contributing to around 48% of the firm's 2024 adjusted earnings. The Asia segment contributes around 25% of earnings, mainly tied to Japan. The company also holds leading market positions in Mexico and Chile, with the Latin America segment contributing around 13% of 2024 earnings. The EMEA and MetLife Holdings segments contributed around 4% and 10% of 2024 earnings, respectively.
Metlife trades on the NYSE stock market under the symbol MET.
As of February 12, 2026, MET stock price declined to $77.36 with 3,934,001 million shares trading.
MET has a beta of 1.03, meaning it tends to be more sensitive to market movements. MET has a correlation of 0.48 to the broad based SPY ETF.
MET has a market cap of $50.97 billion. This is considered a Large Cap stock.
Last quarter Metlife reported $24 billion in Revenue and $2.49 earnings per share. This fell short of revenue expectation by $-7 billion and exceeded earnings estimates by $.14.
In the last 3 years, MET traded as high as $89.05 and as low as $48.95.
The top ETF exchange traded funds that MET belongs to (by Net Assets): VTI, VOO, VO, IVV, SPY.
MET has underperformed the market in the last year with a return of -3.7%, while the SPY ETF gained +14.1%. In the last 3 month period, MET fell short of the market, returning -2.8%, while SPY returned 0.0%. However, in the most recent 2 weeks MET has outperformed the stock market by returning -0.4%, while SPY returned -1.8%.
MET support price is $77.76 and resistance is $80.02 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that MET shares will trade within this expected range on the day.